Progesterone Treatment in Female Smokers - 12
NCT00000295
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
NIH
Sponsor class
Conditions
Tobacco Use Disorder
Interventions
DRUG:
Micronized Progesterone
Sponsor
National Institute on Drug Abuse (NIDA)
Collaborators
[object Object]